Increasing Collaborations...

...throughout Regions 1 and 2

Advancing Research...

Join a Biospecimens Workgroup

Together we can minimize cancer health disparities...

...and improve the health of those we serve.

Promoting mentorship...

...supporting future investigators.

Using technology... advance research integration.

Connecting trainees and mentors ... promote mentored career development.

From high school investigators to junior investigators...

...committed to expanding training opportunities in cancer and cancer health disparities research.

Tuesday, February 17, 2015

R2R: Tools of the Trade Putting Public Health Evidence in Action

Tools of the Trade: Putting Public Health Evidence in Action
Tuesday, February 24, 2015, 2:00 p.m. – 3:00 p.m. ET

This year, we celebrate the 5th Anniversary of the NCI Research to Reality community of practice. R2R was developed to engage researchers and practitioners in an ongoing discussion around moving cancer control research into practice.  R2R will only be partially successful if we fail to build capacity for others to join this essential conversation. We are delighted therefore that our February cyber-seminar will introduce a newly released curriculum designed to train community program planners and health educators to locate, select, adapt and implement evidence-based strategies into practice. 

Putting Public Health Evidence in Action is Health is an interactive seven-module training curriculum developed by the Cancer Prevention and Control Research Network (CPCRN).  CPCRN is a network of eight centers that receive funding from the Centers for Disease Control and Prevention and the National Cancer Institute.  The training curriculum is intended for public health practitioners, state and local health department staff, health educators, healthcare providers, community advocates, academic/research faculty and staff, faith-based leaders, and other members of community-based organizations. 

Drs. Jennifer Leeman and Cam Escoffery will introduce the curriculum and how you might adapt and use it to train your staff, students, and community partners.  Following their presentations, we will host a robust, interactive discussion with you about your experiences building the capacity of others to move evidence-based programs and policies into practice. 


Jennifer Leeman, DrPH, MDIV
Assistant Professor, UNC School of Nursing
University of North Carolina at Chapel Hill
CPCRN Position: Principal Investigator

Cam Escoffery, PhD, MPH, CHES
Assistant Professor, Emory University
Rollins School of Public Health
CPCRN Position: Co-Investigator

Please click on the following link for more information and to register for this event:

Following registration, you will receive a confirmation email with the toll free number, web URL,and participant passcode.  This cyber-seminar will be archived on the Research to Reality (R2R) web site at approximately one week following the presentation.

If you have missed any of the previous cyber-seminars, you can view them all on the R2R Archive.  Watch the presentations, and join in the discussions.   

For more information on the cyber-seminar series please email

Tuesday, February 3, 2015

Dr. Hébert: MIR ratio possible global disparities indicator in #cancer screening/treatment . #ArnoldSchool @CPCPUSC

Hébert and co-author determine mortality-to-incidence ratio may serve as indicator for global disparities in colorectal cancer screening and treatment

January 29, 2015
James Hébert
James Hébert
James Hébert, Health Sciences Distinguished Professor in the Department of Epidemiology and Biostatistics at the Arnold School of Public Health, and Vasu Sunkara (Harvard University) have determined that the mortality-to-incidence ratio (MIR) can be used to identify disparities in deaths due to colorectal cancer that reflect differences in screening and treatment globally. The MIR is a measure popularized by Hébert and colleagues in USC’s Cancer Prevention and Control Program that compares cancer mortality in relation to incidence. In other words, scientists use MIRs to take into account incidence and mortality to examine differences in survival rates for various types of cancer.
In their study, published in the journal Cancer, the authors examined the relationship between colorectal cancer MIRs and health system rankings, which included factors such as health care financing, responsiveness to health needs and availability of screening facilities, for all 34 Organisation for Economic Cooperation and Development (OECD) countries. The researchers found that countries with lower-than-expected MIRs (i.e., fewer deaths than expected based on their incidence rate) are more likely to have higher health system rankings. Accordingly, these countries also are more likely to have formal colorectal cancer screening programs in place and a larger percentage of the population participating in the screenings. Conversely, countries with higher-than-expected MIRs, where mortality rates exceed expectations based on incidence, had lower health system rankings and were less likely to have strong screening programs and high participation rates. These correlations suggest that the MIR has potential as an indicator of the long-term success of global cancer surveillance programs.
“The MIR appears to be a promising method to help identify global populations at risk for cancers that can be screened and effectively treated,” says Sunkara. “In this capacity, it is potentially a useful tool for monitoring an important cancer outcome to inform and improve health policy at a national and international level.”
Hébert, who also serves as director of the Cancer Prevention and Control Program at the Arnold School, has used the MIR previously at the state (i.e., in both South Carolina and Georgia) and national level within the U.S. “The use of the MIR internationally opens new possibilities for testing the relationship between this important indicator of cancer outcome and characteristics of countries’ health care delivery systems,” he adds.
The study’s evidence-based confirmation that the MIR can be used in this manner is timely given that inequalities in cancer screening, incidence, treatment and survival continue to worsen globally. The authors suggest that countries with high MIR values should consider using MIR-based analyses to help drive health care financing and policy reform to increase access to high-quality colorectal screening programs and enhance health system infrastructure and performance overall. Because colorectal cancer is one of the most preventable forms of cancer and yet one of the most expensive to treat, shifting to this type of approach will be both cost-effective and life-saving.